For patients with DCIS, risk of death higher for women under 35, black women

the ONA take:

Women diagnosed with ductal carcinoma in situ have a 20-year breast cancer-specific death rate of 3.3%, with a higher death rate among women diagnosed before age 35 and black women, according to a study published online ahead of print in JAMA Oncology.

For the study, researchers analyzed data from 108,196 women diagnosed with ductal carcinoma in situ of the breast included in the Surveillance, Epidemiology and End Results (SEER) database and compared their risk of dying of breast cancer with that of women in the general population.

Results showed that the 10-year breast cancer-specific death rate after cancer diagnosis was 1.1% and the 20-year rate was 3.3%. Researchers found that women who had a ductal carcinoma in situ diagnosis have a 1.8 times higher risk of death compared those in the general population.

The study also demonstrated that age at diagnosis and black ethnicity were risk factors for death following a ductal carcinoma in situ diagnosis.

For patients with DCIS, risk of death higher for women under 35, black women
Women diagnosed with ductal carcinoma in situ have a 20-year breast cancer-specific death rate of 3.3%.
Researchers estimate the 20-year breast cancer-specific death rate for women diagnosed with ductal carcinoma in situ to be 3.3 percent, although the death rate is higher for women diagnosed before age 35 and for black women, according to an article published online by JAMA Oncology.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs